Gastroesopheal Reflux Disease podcast cover art
9 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Gastroesopheal Reflux Disease

Published:

Topic overview

Surgical perspective on evaluating and managing gastroesophageal reflux disease, covering initial PPI trial, diagnostic endoscopy to rule out Barrett's esophagus, and pH monitoring to confirm diagnosis before long-term therapy. Discussion emphasizes stepwise workup and concerns about indefinite PPI use in young patients.

Key takeaways

  • Initial GERD management: trial 20mg daily PPI for 6 weeks before considering surgical referral or advanced workup
  • EGD mandatory for patients requiring chronic PPI therapy to rule out Barrett's esophagus and assess for esophagitis
  • Ambulatory pH monitoring (Bravo) indicated when symptoms persist but endoscopy shows no esophagitis, hernia, or Barrett's
  • Attempt PPI discontinuation after symptom resolution to avoid long-term complications (osteoporosis, other PPI-associated risks)
  • Confirm true GERD diagnosis with objective testing before committing young patients to indefinite acid suppression therapy

Keywords

Hashtags

Transcript

Click "Show Transcript" to view the full text (35393 characters)

Comments

Loading comments...